Encapsulate

Encapsulate

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://encapsulate.bio

Last Round

Grant

Jul 8, 2025

Total Funding Raised

$7.47M

Company Overview

Encapsulate is a biotechnology company that develops automated tumor-on-a-chip systems to provide personalized cancer therapy recommendations by testing treatments on patient-derived microtumors.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Drug Discovery, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

tumor-on-a-chipTOCdrug sensitivity testingprecision medicinepatient-derived organoidsfunctional precision medicinepersonalized oncologypreclinical drug screeningpatient stratificationex vivo testingtumor biobankcancer diagnosticsorgan-on-a-chipmicrofluidicsmetastasis-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Encapsulate Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Encapsulate Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 8, 2025
GrantJun 15, 2025
SeedNov 19, 2024
GrantNov 18, 2024
Pre SeedMar 15, 2023
Grant
May 15, 2022

Key People

Founding team and executive leadership

Leila Daneshmandi

Co-Founder And COO

Founding Team

Armin Rad

CEO, Co-Founder

Founding Team

Encapsulate Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2025

    Received $3.63M from NASA for a microgravity cancer device.

  • Jul 8, 2025

    $1.25M raised in a grant round.

Encapsulate Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Encapsulate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Encapsulate's valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range13
Year Founded2019
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.